Biology:Enterococcus durans

From HandWiki
Short description: Species of bacterium

Enterococcus durans
Scientific classification edit
Domain: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Lactobacillales
Family: Enterococcaceae
Genus: Enterococcus
Species:
E. durans
Binomial name
Enterococcus durans
(ex Sherman and Wing, 1937) Collins et al., 1984

Enterococcus durans is a species of Enterococcus.[1] It is a gram-positive, catalase- and oxidase-negative, coccus bacterium. The organism is also a facultative anaerobic organism.[2] Prior to 1984, it was known as Streptococcus durans.[3]

Certain strains have also been identified as producers of anti-inflammatory agents, which are being studied in medical research.[4] E. durans is less commonly isolated in clinical infections than E. faecalis and E. faecium, but it has been increasingly recognized in hospital settings, particularly in patients with urinary catheters and prolonged antibiotic exposure.[5][6]

Metabolism

In terms of metabolism, E. durans primarily shares its substrate utilization profile with E. faecium. It can metabolize L-arabinose (weakly), melibiose and lactose which aids in its biochemical distinction from E. faecalis. E. durans is often misidentified in clinical diagnostics due to phenotypic overlap with E. faecium, especially when relying on MALDI-TOF mass spectrometry. Whole-genome sequencing are increasingly recommended for accurate identification and characterization.[7]

Pathogenesis

Enterococcus durans is an infrequent cause of infections in humans. Several cases of E. durans endocarditis have been reported in patients with valve replacements.[8][9][10] One case of bacterial endocarditis in a patient with an implantable cardioverter-defibrillator (ICD) has also been reported.[11]

References

  1. ↑ "Differentiation and identification of Enterococcus durans, E. hirae and E. villorum". J. Appl. Microbiol. 92 (5): 821–7. 2002. doi:10.1046/j.1365-2672.2002.01586.x. PMID 11972684. 
  2. ↑ Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(6):1749-1757. doi:10.1099/mic.0.026385-0.
  3. ↑ Collins, M. D.; Jones, D.; Farrow, J. A. E.; Kilpper-Bälz, R.; Schleifer, K. H. (1984). "Enterococcus avium nom. rev., comb. nov.; E. casseliflavus nom. rev., comb. nov.; E. durans nom. rev., comb. nov.; E. gallinarum comb. nov.; and E. malodoratus sp. nov.". International Journal of Systematic and Evolutionary Microbiology 34 (2): 220–223. doi:10.1099/00207713-34-2-220. ISSN 1466-5034. 
  4. ↑ Carasi, P., Racedo, S. M., Jacquot, C., Elie, A. M., Serradell, M. de los Á., & Urdaci, M. C. (2017). Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance. Frontiers in Immunology, 8, 88. http://doi.org/10.3389/fimmu.2017.00088
  5. ↑ Karlsson, Philip A.; Pärssinen, Julia; Danielsson, Erik A.; Fatsis-Kavalopoulos, Nikos; Frithiof, Robert; Hultström, Michael; Lipcsey, Miklos; Järhult, Josef D. et al. (2023-02-07). "Antibiotic use during coronavirus disease 2019 intensive care unit shape multidrug resistance bacteriuria: A Swedish longitudinal prospective study". Frontiers in Medicine 10. doi:10.3389/fmed.2023.1087446. ISSN 2296-858X. PMID 36824610. 
  6. ↑ Karlsson, Philip A.; Bolin, Christian; Spång, Labolina; Frithiof, Robert; Hultström, Michael; Lipcsey, Miklos; Wang, Helen; Järhult, Josef D. (2025-03-04). "Bacteriuria and antibiotic use during the third wave of COVID-19 intensive care in Sweden" (in en). Infectious Diseases 57 (3): 284–293. doi:10.1080/23744235.2024.2423884. ISSN 2374-4235. PMID 39509144. 
  7. ↑ Karlsson, Philip A.; Zhang, Taoran; Järhult, Josef D.; Joffré, Enrique; Wang, Helen (2025-06-12). Ponraj, Vittal Prakash. ed. "Heterogeneity and metabolic diversity among Enterococcus species during long-term colonization" (in en). Microbiology Spectrum 13 (8). doi:10.1128/spectrum.03160-24. ISSN 2165-0497. PMID 40503823. 
  8. ↑ Sunbul, Mustafa; Cerik, Hatun O.; Cerik, Bugra; Gulel, Okan; Leblebicioglu, Hakan (2018). "Enterococcus durans Endocarditis". American Journal of Therapeutics 25 (6): e663–e665. doi:10.1097/MJT.0000000000000519. ISSN 1536-3686. PMID 28590307. 
  9. ↑ Zala, Alkesh; Collins, Nicholas (2016). "Enterococcus durans Prosthetic Valve Endocarditis: A Previously Unreported Clinical Entity". Heart, Lung & Circulation 25 (10): e133–136. doi:10.1016/j.hlc.2016.01.010. ISSN 1444-2892. PMID 27523465. 
  10. ↑ Al Shehri, Mohammed; Zarak, Muhammad Samsoor; Sarwari, Arif R. (2020). "Late Prosthetic Valve Infective Endocarditis by Enterococcus durans". Journal of Global Infectious Diseases 12 (3): 152–155. doi:10.4103/jgid.jgid_99_19. ISSN 0974-777X. PMID 33343168. 
  11. ↑ Radovanovic, Milan; Jevtic, Djordje; Barsoum, Michel K.; Patel, Janki; Dumic, Igor (2022-02-17). "Enterococcus durans Cardiac Implantable Electronic Device Lead Infection and Review of Enterococcus durans Endocarditis Cases". Medicina 58 (2): 307. doi:10.3390/medicina58020307. ISSN 1648-9144. PMID 35208630. 

Further reading

  • Nami, Yousef; Abdullah, Norhafizah; Haghshenas, Babak; Radiah, Dayang; Rosli, Rozita; Khosroushahi, Ahmad (August 2014). "Probiotic assessment of Enterococcus durans 6HL and Lactococcus lactis 2HL isolated from vaginal microflora". Journal of Medical Microbiology 63 (Part 8): 1044–1051. doi:10.1099/jmm.0.074161-0. PMID 24913559. 

Wikidata ☰ Q5380224 entry